Literature DB >> 24392342

Co-existent choroidal neovascular membrane and macular hole in pathologic myopia: a long follow-up clinical outcome and literature review.

Zhi-Qing Chen1, Ji-Jian Lin1, Pan-Pan Ye1, Li Zhang1, Xiao-Yun Fang1.   

Abstract

Choroidal neovascularization (CNV) is an uncommon complication associated with a macular hole. In this case report of a rare condition, we present a pathologic myopia patient with a co-existent macular hole and choroidal neovascular membrane. The patient was treated with photodynamic therapy for CNV, and then vitreous surgery for the retinal detachment and macular hole. At the end of 4 years follow-up, her visual acuity was improved to 0.1 while the macular hole remained open. Optical coherence tomography is a useful inspection method of the diagnosis of CNV and macular hole.

Entities:  

Keywords:  choroidal neovascularization; macular hole; pathologic myopia

Year:  2013        PMID: 24392342      PMCID: PMC3874533          DOI: 10.3980/j.issn.2222-3959.2013.06.25

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  19 in total

1.  Visual improvement following sequential photodynamic therapy and vitrectomy for coexisting macular hole and choroidal neovascularization.

Authors:  Franco M Recchia; George A Williams
Journal:  Retina       Date:  2003-02       Impact factor: 4.256

2.  Surgical management of retinal detachment associated with myopic macular hole: anatomic and functional status of the macula.

Authors:  Mikio Ichibe; Toyohisa Yoshizawa; Kenji Murakami; Masayuki Ohta; Yoshimi Oya; Susumu Yamamoto; Shigeo Funaki; Haruko Funaki; Yumi Ozawa; Eriko Baba; Haruki Abe
Journal:  Am J Ophthalmol       Date:  2003-08       Impact factor: 5.258

3.  Efficacy of primary silicone oil tamponade for the treatment of retinal detachment caused by macular hole in high myopia.

Authors:  Akira Nishimura; Masayo Kimura; Yoshiaki Saito; Kazuhisa Sugiyama
Journal:  Am J Ophthalmol       Date:  2010-12-04       Impact factor: 5.258

4.  Choroidal neovascularization in an eye with a macular hole.

Authors:  T Smith; L E Magargal; L A Donoso; H O Magargal; E Robb-Doyle
Journal:  Ann Ophthalmol       Date:  1989-09

5.  Long-term changes in axial length in adult eyes with pathologic myopia.

Authors:  Natsuko Saka; Kyoko Ohno-Matsui; Noriaki Shimada; Shin-Ichi Sueyoshi; Natsuko Nagaoka; Wakako Hayashi; Kengo Hayashi; Muka Moriyama; Ariko Kojima; Kenjiro Yasuzumi; Takeshi Yoshida; Takashi Tokoro; Manabu Mochizuki
Journal:  Am J Ophthalmol       Date:  2010-08-04       Impact factor: 5.258

6.  Retinal detachment associated with a macular hole in severely myopic eyes.

Authors:  J Akiba; S Konno; A Yoshida
Journal:  Am J Ophthalmol       Date:  1999-11       Impact factor: 5.258

7.  The types and severity of high myopic maculopathy in Chinese patients.

Authors:  Hui Chen; Feng Wen; Haitao Li; Chengguo Zuo; Xiongze Zhang; Shizhou Huang; Guangwei Luo
Journal:  Ophthalmic Physiol Opt       Date:  2011-07-18       Impact factor: 3.117

8.  Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia.

Authors:  Faik Gelisken; Werner Inhoffen; Alexander Hermann; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-17       Impact factor: 3.117

9.  Intravitreal bevacizumab for extrafoveal choroidal neovascularization secondary to pathologic myopia.

Authors:  Maurizio B Parodi; Pierluigi Iacono; Alessandro Papayannis; Stylianos Kontadakis; Maria L Cascavilla; Ilaria Zucchiatti; Francesco Bandello
Journal:  Retina       Date:  2013-03       Impact factor: 4.256

10.  Causative factors of retinal detachment in macular holes.

Authors:  H Morita; H Ideta; K Ito; J Yonemoto; K Sasaki; S Tanaka
Journal:  Retina       Date:  1991       Impact factor: 4.256

View more
  1 in total

1.  Management of coexistent choroidal neovascular membrane and macular hole with serous detachment in a case of pathological myopia: challenges and dilemmas.

Authors:  Naresh Babu Kannan; Sagnik Sen; Obuli Ramachandran; Kim Ramasamy
Journal:  BMJ Case Rep       Date:  2020-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.